RS49691B - Liofilizovan preparat ljudskog morfogenetskog faktora mp52 kosti - Google Patents
Liofilizovan preparat ljudskog morfogenetskog faktora mp52 kostiInfo
- Publication number
- RS49691B RS49691B YUP-349/99A YU34999A RS49691B RS 49691 B RS49691 B RS 49691B YU 34999 A YU34999 A YU 34999A RS 49691 B RS49691 B RS 49691B
- Authority
- RS
- Serbia
- Prior art keywords
- bone morphogenetic
- morphogenetic factor
- lyophilized composition
- factor human
- human
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Liofilizovan preparat humanog koštanog morfogenetskog faktora MP52 i, naznačen time, što sadrži smešu humanog morfogenetskog faktora MP52 i manitola u težinskom odnosu 1:5-50. Prijava sadrži još 1 nezavisan i 2 zavisna patentna zahteva.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1634997 | 1997-01-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
YU34999A YU34999A (sh) | 2002-08-12 |
RS49691B true RS49691B (sr) | 2007-12-31 |
Family
ID=11913900
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YUP-349/99A RS49691B (sr) | 1997-01-30 | 1998-01-29 | Liofilizovan preparat ljudskog morfogenetskog faktora mp52 kosti |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP0972520B9 (sr) |
JP (1) | JP4209948B2 (sr) |
KR (1) | KR100548107B1 (sr) |
CN (1) | CN1152712C (sr) |
AP (1) | AP983A (sr) |
AT (1) | ATE302021T1 (sr) |
AU (1) | AU737595B2 (sr) |
BR (1) | BR9807537B1 (sr) |
CA (1) | CA2278546C (sr) |
DE (1) | DE69831223T9 (sr) |
DK (1) | DK0972520T3 (sr) |
EA (1) | EA001579B1 (sr) |
ES (1) | ES2244043T3 (sr) |
HU (1) | HU226554B1 (sr) |
IL (2) | IL130967A0 (sr) |
NO (1) | NO322334B1 (sr) |
NZ (1) | NZ336509A (sr) |
PL (1) | PL189381B1 (sr) |
RS (1) | RS49691B (sr) |
SI (1) | SI0972520T1 (sr) |
TR (1) | TR199901832T2 (sr) |
WO (1) | WO1998033514A1 (sr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69814352T3 (de) † | 1997-02-07 | 2009-08-13 | Stryker Corp., Kalamazoo | Matrixlose osteogene vorrichtungen und implantate und verfahren zu deren verwendung |
EP1434569A1 (en) * | 2001-10-09 | 2004-07-07 | CellFactors plc | Therapeutic biological product and method for formation of new vascularised bone |
BR0214275A (pt) | 2001-11-19 | 2004-09-21 | Scil Technology Gmbh | Dispositivo tendo propriedades osteocondutora e osteoindutora |
ES2260685T3 (es) | 2002-09-10 | 2006-11-01 | Scil Technology Gmbh | Implante metalico recubierto, a una concentracion de oxigeno reducida, con proteina osteoinductora. |
US20060204511A1 (en) * | 2003-08-05 | 2006-09-14 | Bouwstra Jan B | Use of recombinant or synthetic gelatin as stabiliser in vaccines |
JP2007534633A (ja) * | 2003-11-10 | 2007-11-29 | アライバ−プロメティック インコーポレイティド | ヒト・アルファ1−抗トリプシン製剤 |
ES2350939T3 (es) | 2004-03-10 | 2011-01-28 | Scil Technology Gmbh | Implantes recubiertos, su fabricación y uso de los mismos. |
US10216709B2 (en) | 2015-05-22 | 2019-02-26 | Microsoft Technology Licensing, Llc | Unified messaging platform and interface for providing inline replies |
US20160344677A1 (en) | 2015-05-22 | 2016-11-24 | Microsoft Technology Licensing, Llc | Unified messaging platform for providing interactive semantic objects |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0080879B1 (en) * | 1981-11-28 | 1986-10-01 | Sunstar Kabushiki Kaisha | Pharmaceutical composition containing interferon in stable state |
US5037644A (en) * | 1986-10-27 | 1991-08-06 | Cetus Corporation | Pharmaceutical compositions of recombinant interleukin-2 and formulation processes |
AU663328B2 (en) * | 1991-06-21 | 1995-10-05 | Genetics Institute, Llc | Pharmaceutical formulations of osteogenic proteins |
JP2966592B2 (ja) * | 1991-07-20 | 1999-10-25 | 萩原 義秀 | 安定化されたヒトモノクローナル抗体製剤 |
WO1993016099A2 (en) * | 1992-02-12 | 1993-08-19 | Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh | Dna sequences encoding novel growth/differentiation factors |
CA2093836A1 (en) * | 1992-04-24 | 1993-10-25 | Wayne Gombotz | Biodegradable tgf-.beta. delivery system for bone regeneration |
DE4239877C1 (de) * | 1992-11-27 | 1994-03-17 | Boehringer Ingelheim Int | Stabilisierte Superoxid-Dismutase (SOD)-Zusammensetzung |
WO1996029095A1 (en) * | 1995-03-21 | 1996-09-26 | Applied Research Systems Ars Holding N.V. | Hcg liquid formulations |
DE69636728D1 (de) * | 1995-04-19 | 2007-01-04 | Bioph Biotech Entw Pharm Gmbh | Neues protein und verfahren zu dessen herstellung |
-
1998
- 1998-01-29 SI SI9830798T patent/SI0972520T1/sl unknown
- 1998-01-29 CN CNB988019841A patent/CN1152712C/zh not_active Expired - Fee Related
- 1998-01-29 RS YUP-349/99A patent/RS49691B/sr unknown
- 1998-01-29 AT AT98901044T patent/ATE302021T1/de active
- 1998-01-29 BR BRPI9807537-3A patent/BR9807537B1/pt not_active IP Right Cessation
- 1998-01-29 WO PCT/JP1998/000371 patent/WO1998033514A1/ja active IP Right Grant
- 1998-01-29 IL IL13096798A patent/IL130967A0/xx active IP Right Grant
- 1998-01-29 CA CA002278546A patent/CA2278546C/en not_active Expired - Fee Related
- 1998-01-29 HU HU0002386A patent/HU226554B1/hu not_active IP Right Cessation
- 1998-01-29 NZ NZ336509A patent/NZ336509A/xx not_active IP Right Cessation
- 1998-01-29 AP APAP/P/1999/001602A patent/AP983A/en active
- 1998-01-29 JP JP53271798A patent/JP4209948B2/ja not_active Expired - Fee Related
- 1998-01-29 ES ES98901044T patent/ES2244043T3/es not_active Expired - Lifetime
- 1998-01-29 PL PL98334852A patent/PL189381B1/pl not_active IP Right Cessation
- 1998-01-29 DK DK98901044T patent/DK0972520T3/da active
- 1998-01-29 AU AU56791/98A patent/AU737595B2/en not_active Ceased
- 1998-01-29 TR TR1999/01832T patent/TR199901832T2/xx unknown
- 1998-01-29 EP EP98901044A patent/EP0972520B9/en not_active Expired - Lifetime
- 1998-01-29 EA EA199900694A patent/EA001579B1/ru not_active IP Right Cessation
- 1998-01-29 DE DE69831223T patent/DE69831223T9/de active Active
- 1998-01-29 KR KR1019997006833A patent/KR100548107B1/ko not_active IP Right Cessation
-
1999
- 1999-07-15 IL IL130967A patent/IL130967A/en not_active IP Right Cessation
- 1999-07-29 NO NO19993702A patent/NO322334B1/no not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0950665A4 (en) | PHYSIOLOGICALLY ACTIVE MODIFIED PROTEINS AND DRUG COMPOSITIONS CONTAINING THEM | |
ID23807A (id) | Metoda dan komposisi yang mengandung-semen untuk digunakan dalam bawah tanah | |
ID24520A (id) | Analog-analog peptida lh-rh, penggunaannya dan komposisi farmasi yamg mengandungnya | |
FI952119A0 (fi) | Stabiili pakastekuivattu koostumus, joka sisältää proteiinia ja testipakkaus | |
BG101132A (en) | Pyridoanilated thienyl and furanyl oxazolidinons | |
HK1015269A1 (en) | Use of r-enantiomer of n-propargyl-1-aminoindan, salts, and compositions thereof | |
HUP0100101A3 (en) | Prostaglandin agonists, pharmaceutical compositions comprising thereof and their use | |
CA2281562A1 (en) | Forskolin for promoting lean body mass | |
SI1019358T2 (sl) | 3,3-diarilpropilamini, njihova uporaba in priprava | |
IL127366A0 (en) | Insulin preparations containing NaCl | |
HK1030939A1 (en) | Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists | |
IL133997A (en) | 2-[pyrazolyl- and triazolyl-3'-oxymethylene] phenylisoxazolones, -triazolones and -tetrazolones, their preparation and compositions comprising them | |
DE69830119D1 (de) | Teigzusammensetzung und derer Herstellung | |
EE200000226A (et) | 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon | |
HUP9902586A3 (en) | Mixtures derived from grains of eugenia jambolana lamarck, preparation and use of said mixtures and some of their constituents as medicaments | |
HUP9801256A3 (en) | 5'-deoxy-cytidine derivatives, preparation and use thereof and pharmaceutical compositions | |
RS49691B (sr) | Liofilizovan preparat ljudskog morfogenetskog faktora mp52 kosti | |
HUT71377A (en) | Artificial tanning cosmetical compositions based on dihydroxyacetone, preparation and use of them | |
DE69634489D1 (de) | Adenovirus dodekahedrischer proteinkomplex, dieser enthaltende zusammensetzung und verwendungen davon | |
EP0915826A4 (en) | SPASMOLYTIC AGENT FOR SMOOTH MUSCLE, COMPOSITIONS AND METHODS OF USE RELATING TO THIS AGENT | |
ID23156A (id) | Turunan-turunan amidina, proses pembuatan komposisi dan penggunaannya | |
BG101849A (en) | Bicyclic tachyquinine antagonists, their preparation and use in pharmaceutical compositions | |
EE200000207A (et) | 8-asabitsüklo[3.2.1]oktaan-3-metaanamiini derivaadid, nende valmistamine ja terapeutiline kasutamine | |
ATE196914T1 (de) | Lh-rh analoge mit starrer konformation, deren verwendungen und pharmazeutische zusammensetzungen | |
HUP9903098A3 (en) | Combination comprising vx478, zidovudine and/or 1592u89 and pharmaceutical composition containing them |